Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Gains from Investment Securities (2016 - 2020)

Historic Gains from Investment Securities for Forte Biosciences (FBRX) over the last 5 years, with Q4 2020 value amounting to $5000.0.

  • Forte Biosciences' Gains from Investment Securities fell 9903.2% to $5000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was -$197000.0, marking a year-over-year decrease of 13813.98%. This contributed to the annual value of $366000.0 for FY2021, which is 4409.45% up from last year.
  • Forte Biosciences' Gains from Investment Securities amounted to $5000.0 in Q4 2020, which was down 9903.2% from $1.0 million recorded in Q3 2020.
  • Over the past 5 years, Forte Biosciences' Gains from Investment Securities peaked at $1.0 million during Q3 2020, and registered a low of -$916000.0 during Q1 2020.
  • Its 5-year average for Gains from Investment Securities is $185658.2, with a median of $134325.5 in 2016.
  • The largest annual percentage gain for Forte Biosciences' Gains from Investment Securities in the last 5 years was 79250.0% (2017), contrasted with its biggest fall of 75555.56% (2017).
  • Over the past 5 years, Forte Biosciences' Gains from Investment Securities (Quarter) stood at $80000.0 in 2016, then skyrocketed by 792.5% to $714000.0 in 2017, then crashed by 73.58% to $188651.0 in 2018, then surged by 173.8% to $516521.0 in 2019, then crashed by 99.03% to $5000.0 in 2020.
  • Its Gains from Investment Securities stands at $5000.0 for Q4 2020, versus $1.0 million for Q3 2020 and $821910.0 for Q2 2020.